107 related articles for article (PubMed ID: 8164574)
1. Dose distributions produced by a shielded vaginal cylinder using a high-activity iridium-192 source.
Waterman FM; Holcomb DE
Med Phys; 1994 Jan; 21(1):101-6. PubMed ID: 8164574
[TBL] [Abstract][Full Text] [Related]
2. A monte carlo dosimetry study of vaginal 192Ir brachytherapy applications with a shielded cylindrical applicator set.
Lymperopoulou G; Pantelis E; Papagiannis P; Rozaki-Mavrouli H; Sakelliou L; Baltas D; Karaiskos P
Med Phys; 2004 Nov; 31(11):3080-6. PubMed ID: 15587661
[TBL] [Abstract][Full Text] [Related]
3. Measurement and calculation of heterogeneity correction factors for an Ir-192 high dose-rate brachytherapy source behind tungsten alloy and steel shields.
Kirov AS; Williamson JF; Meigooni AS; Zhu Y
Med Phys; 1996 Jun; 23(6):911-9. PubMed ID: 8798161
[TBL] [Abstract][Full Text] [Related]
4. Computation of relative dose distribution and effective transmission around a shielded vaginal cylinder with 192Ir HDR source using MCNP4B.
Sureka CS; Aruna P; Ganesan S; Sunny CS; Subbaiah KV
Med Phys; 2006 Jun; 33(6):1552-61. PubMed ID: 16872062
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric accuracy of a deterministic radiation transport based 192Ir brachytherapy treatment planning system. Part II: Monte Carlo and experimental verification of a multiple source dwell position plan employing a shielded applicator.
Petrokokkinos L; Zourari K; Pantelis E; Moutsatsos A; Karaiskos P; Sakelliou L; Seimenis I; Georgiou E; Papagiannis P
Med Phys; 2011 Apr; 38(4):1981-92. PubMed ID: 21626931
[TBL] [Abstract][Full Text] [Related]
6. A BrachyPhantom for verification of dose calculation of HDR brachytherapy planning system.
Austerlitz C; Campos CA
Med Phys; 2013 Nov; 40(11):112103. PubMed ID: 24320456
[TBL] [Abstract][Full Text] [Related]
7. Dose distributions produced by shielded applicators using 241Am for intracavitary irradiation of tumors in the vagina.
Muench PJ; Nath R
Med Phys; 1992; 19(5):1299-306. PubMed ID: 1435613
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of intracavitary applicators in 192Ir-HDR brachytherapy.
Ye SJ; Brezovich IA; Shen S; Duan J; Popple RA; Pareek PN
Med Phys; 2004 Jul; 31(7):2097-106. PubMed ID: 15305463
[TBL] [Abstract][Full Text] [Related]
9. Interstitial rotating shield brachytherapy for prostate cancer.
Adams QE; Xu J; Breitbach EK; Li X; Enger SA; Rockey WR; Kim Y; Wu X; Flynn RT
Med Phys; 2014 May; 41(5):051703. PubMed ID: 24784369
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric characterization of a novel intracavitary mold applicator for 192Ir high dose rate endorectal brachytherapy treatment.
Poon E; Reniers B; Devic S; Vuong T; Verhaegen F
Med Phys; 2006 Dec; 33(12):4515-26. PubMed ID: 17278803
[TBL] [Abstract][Full Text] [Related]
11. Accounting for high Z shields in brachytherapy using collapsed cone superposition for scatter dose calculation.
Tedgren AK; Ahnesjö A
Med Phys; 2003 Aug; 30(8):2206-17. PubMed ID: 12945986
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the relative dose distribution around an 192Ir line source using a liquid ionization chamber.
Bahar-Gogani J; Wickman G; Johansson L; Johansson BE
Med Phys; 1999 Sep; 26(9):1932-42. PubMed ID: 10505883
[TBL] [Abstract][Full Text] [Related]
13. On the validity of the superposition principle in dose calculations for intracavitary implants with shielded vaginal colpostats.
Markman J; Williamson JF; Dempsey JF; Low DA
Med Phys; 2001 Feb; 28(2):147-55. PubMed ID: 11243337
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric analysis of a shielded applicator for nasopharyngeal carcinoma intracavitary brachytherapy: Monte Carlo calculation.
Chen LX; Liu XW; You RA; Qian JY; Qi ZY; Deng XW; Tsao SY
Med Phys; 2006 Mar; 33(3):761-9. PubMed ID: 16878578
[TBL] [Abstract][Full Text] [Related]
15. Accuracy assessment of the superposition principle for evaluating dose distributions of elongated and curved 103Pd and 192Ir brachytherapy sources.
Bannon EA; Yang Y; Rivard MJ
Med Phys; 2011 Jun; 38(6):2957-63. PubMed ID: 21815369
[TBL] [Abstract][Full Text] [Related]
16. Scatter and attenuation measurements at distances greater than 10 cm from an 192Ir source.
Mauceri T; Biggs P; Beatty J; Flynn D
Med Phys; 1999 Jan; 26(1):97-9. PubMed ID: 9949404
[TBL] [Abstract][Full Text] [Related]
17. Determination of absorbed dose in water at the reference point d(r0, theta0) for an 192Ir HDR brachytherapy source using a Fricke system.
Austerlitz C; Mota HC; Sempau J; Benhabib SM; Campos D; Allison R; DeAlmeida CE; Zhu D; Sibata CH
Med Phys; 2008 Dec; 35(12):5360-5. PubMed ID: 19175095
[TBL] [Abstract][Full Text] [Related]
18. Dosimetry of 192Ir wires for LDR interstitial brachytherapy following the AAPM TG-43 dosimetric formalism.
Karaiskos P; Papagiannis P; Angelopoulos A; Sakelliou L; Baltas D; Sandilos P; Vlachos L
Med Phys; 2001 Feb; 28(2):156-66. PubMed ID: 11243338
[TBL] [Abstract][Full Text] [Related]
19. The use of directional interstitial sources to improve dosimetry in breast brachytherapy.
Lin L; Patel RR; Thomadsen BR; Henderson DL
Med Phys; 2008 Jan; 35(1):240-7. PubMed ID: 18293579
[TBL] [Abstract][Full Text] [Related]
20. A CT-based analytical dose calculation method for HDR 192Ir brachytherapy.
Poon E; Verhaegen F
Med Phys; 2009 Sep; 36(9):3982-94. PubMed ID: 19810471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
